NEPHROS INC Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Nephros Inc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
  • Nephros Inc Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $21.1M, a 4.81% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $21.1M -$1.07M -4.81% Dec 31, 2023 10-K 2024-03-15
Q4 2022 $22.1M +$1.69M +8.26% Dec 31, 2022 10-K 2024-03-15
Q4 2021 $20.5M +$691K +3.5% Dec 31, 2021 10-K 2023-03-23
Q4 2020 $19.8M -$166K -0.83% Dec 31, 2020 10-K 2022-03-03
Q4 2019 $19.9M -$676K -3.28% Dec 31, 2019 10-K 2021-03-01
Q4 2018 $20.6M +$797K +4.02% Dec 31, 2018 10-K 2020-02-27
Q4 2017 $19.8M -$12.1M -37.9% Dec 31, 2017 10-K 2019-03-12
Q4 2016 $31.9M +$983K +3.18% Dec 31, 2016 10-K 2018-02-26
Q4 2015 $30.9M -$514K -1.64% Dec 31, 2015 10-K 2017-03-20
Q4 2014 $31.4M +$1.07M +3.53% Dec 31, 2014 10-K 2016-03-30
Q4 2013 $30.3M +$1.42M +4.9% Dec 31, 2013 10-K 2015-04-15
Q4 2012 $28.9M +$1.27M +4.58% Dec 31, 2012 10-K 2014-03-28
Q4 2011 $27.7M Dec 31, 2011 10-K 2013-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.